While testicular cancer rates have been rising for years in the United States, it's still a relatively uncommon disease.
The American Cancer Society (ACS) estimates that fewer than 9,200 new cases of testicular cancer will be diagnosed in 2023 in the U.S. About 470 people will die from the disease this year.
Receiving any cancer diagnosis can be scary, especially when it's for a rare cancer. Fortunately, testicular cancer can usually be treated successfully. A man's lifetime risk of dying from this disease is about 1 in 5,000, according to the ACS. The five-year relative survival rate for the disease is 95 percent overall. That jumps to 99 percent when it is detected in the localized stage.
Testicular cancer is a disease that tends to affect young and middle-aged men. The average age at diagnosis is about 33 years old. For several decades, the rates of testicular cancer in the U.S. and around the world have increased for unknown reasons, but statistics show the increase has recently slowed.
Early diagnosis and treatment are important, so understanding the disease and the signs and symptoms that accompany it are crucial.